Could targeted drug dosing stamp out malaria in thai hotspots?
NCT ID NCT05052502
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving antimalarial drugs to everyone in high-risk villages and forest workers could lower malaria cases in Thailand. Over 14,000 people took part. The goal was to see if this approach reduces infections from both Plasmodium falciparum and Plasmodium vivax malaria compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Division of Vector Born Diseases, Ministry of Health
Bangkok, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new malaria vaccine slash childhood cases? a massive real-world test seeks answers.
- Can a single dose of tafenoquine finally cure vivax malaria in southeast asia?
- Malaria prevention study pulled before it began
- New vaccines aim to block malaria transmission in africa
- New malaria vaccine trial aims to stop recurrent fever
- New malaria pill for tiny infants studied, but trial stopped early